Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H14N2O6 |
Molecular Weight | 282.2494 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC#CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)NC1=O
InChI
InChIKey=QLOCVMVCRJOTTM-SDNRWEOFSA-N
InChI=1S/C12H14N2O6/c1-2-3-6-4-14(12(19)13-10(6)18)11-9(17)8(16)7(5-15)20-11/h4,7-9,11,15-17H,5H2,1H3,(H,13,18,19)/t7-,8-,9+,11-/m1/s1
Molecular Formula | C12H14N2O6 |
Molecular Weight | 282.2494 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Netivudine [882C, 882C87, BW 882, Py-araU, Zonavir®] is an orally active thymidine analogue which was being investigated as a treatment for herpes zoster virus infections. Netivudine is a nucleoside analog with potent, specific activity against varicella-zoster virus. It is approximately seven times as potent as acyclovir with an in vitro 50% inhibitory concentration of 1 to 2 uM.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8549030
Three groups of eight elderly volunteers received 400 or 800 mg netivudine or placebo once daily for 8 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8245884
The IC50 of Netivudine (882C87) against VZV ranges from 0.6 to 3.8 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:24:56 GMT 2023
by
admin
on
Fri Dec 15 16:24:56 GMT 2023
|
Record UNII |
F7K51T0Q1W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C97452
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000084180
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
DTXSID70233545
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
C067854
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
F7K51T0Q1W
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
C96547
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL1097615
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
DB12606
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
SUB09211MIG
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
55281
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
84558-93-0
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY | |||
|
7275
Created by
admin on Fri Dec 15 16:24:56 GMT 2023 , Edited by admin on Fri Dec 15 16:24:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|